Literature DB >> 16706604

Adipose-derived stem cells for the regeneration of damaged tissues.

Anna M Parker1, Adam J Katz.   

Abstract

As the promise of stem cell-based therapies begins to be realised, and efforts to bring advances to the clinic mount, the source of these cells is increasingly important. The morbidity associated with harvesting stem cells from solid organs and the invasive nature of bone marrow biopsies may limit their practicality for wider clinical applications. An emerging body of literature suggests that adipose tissue may provide an abundant, readily accessible source of cells with similar potential to that described of other adult stem cells. This review will address advances in the use of adipose stem cells in fields as divergent as soft tissue reconstruction and cerebral infarction recovery. Numerous challenges will also be discussed; however, rapidly accumulating advances suggest that adipose stem cells may be as effective as they are abundant.

Entities:  

Mesh:

Year:  2006        PMID: 16706604     DOI: 10.1517/14712598.6.6.567

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  43 in total

1.  Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Authors:  L Zazzeroni; G Lanzoni; G Pasquinelli; C Ricordi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2017-09-29

Review 2.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

Review 3.  Reflections on lineage potential of skeletal muscle satellite cells: do they sometimes go MAD?

Authors:  Gabi Shefer; Zipora Yablonka-Reuveni
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

4.  Non-canonical Wnt signaling enhances differentiation of Sca1+/c-kit+ adipose-derived murine stromal vascular cells into spontaneously beating cardiac myocytes.

Authors:  Nathan J Palpant; So-ichiro Yasuda; Ormond MacDougald; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2007-07-10       Impact factor: 5.000

5.  Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery.

Authors:  Peter J Amos; Sahil K Kapur; Peter C Stapor; Hulan Shang; Stefan Bekiranov; Moshe Khurgel; George T Rodeheaver; Shayn M Peirce; Adam J Katz
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

Review 6.  Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.

Authors:  Mohamadreza Baghaban Eslaminejad; Elham Malakooty Poor
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

7.  Overexpression of the PLAP-1 gene inhibits the differentiation of BMSCs into osteoblast-like cells.

Authors:  Jing Sun; Ting Zhang; Panpan Zhang; Linlin Lv; Yanzhi Wang; Jing Zhang; Shu Li
Journal:  J Mol Histol       Date:  2014-07-20       Impact factor: 2.611

Review 8.  Repair and tissue engineering techniques for articular cartilage.

Authors:  Eleftherios A Makris; Andreas H Gomoll; Konstantinos N Malizos; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Rev Rheumatol       Date:  2014-09-23       Impact factor: 20.543

9.  Transplantation of human adipose-derived stem cells enhances remyelination in lysolecithin-induced focal demyelination of rat spinal cord.

Authors:  Nazem Ghasemi; Shahnaz Razavi; Mohammad Mardani; Ebrahim Esfandiari; Hossein Salehi; Sayyed Hamid Zarkesh Esfahani
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

10.  Human adipose tissue stromal vascular fraction cells differentiate depending on distinct types of media.

Authors:  A Balwierz; U Czech; A Polus; R K Filipkowski; B Mioduszewska; T Proszynski; P Kolodziejczyk; J Skrzeczynska-Moncznik; W Dudek; L Kaczmarek; J Kulig; J Pryjma; A Dembinska-Kiec
Journal:  Cell Prolif       Date:  2008-04-14       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.